A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use

BACKGROUND: Many HIV patients receiving antiretroviral treatment develop lipodystrophy. NEW-FILL(®) is a polylactic acid injected to treat facial lipoatrophy. The objectives of this study were to describe (1) change in quality of life (QoL) of HIV patients treated with NEW-FILL(®) in the management...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Duracinsky, Martin, Leclercq, Pascale, Armstrong, Andrew Richard, Dolivo, Marc, Mouly, Frédéric, Chassany, Olivier
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3598243/
https://ncbi.nlm.nih.gov/pubmed/23425246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-13-92
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars